FPrin

FPrin

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

FPrin is a private, services-oriented company founded in 2020 and headquartered in Cambridge, USA. It provides engineering and product development services specifically for the medical device sector, utilizing a model-based, data-driven methodology to de-risk design and development processes. The company appears to be revenue-generating, serving clients like EOFlow, and positions itself as a partner to overcome common development roadblocks such as missed deadlines, design convergence issues, and reliability concerns. Its work spans areas including drug delivery devices and point-of-care diagnostic systems.

AI / Machine LearningDrug Discovery

Technology Platform

A 'First Principles' engineering services platform utilizing computational modeling (e.g., Monte Carlo simulation, optimization) and targeted empirical testing to de-risk and accelerate medical device design and development.

Opportunities

The growing complexity and cost pressure in medical device development creates strong demand for specialized engineering services that can improve efficiency and reliability.
Expansion into adjacent service areas, such as support for regulatory submissions or software-as-a-medical-device (SaMD), represents a potential growth vector.

Risk Factors

Revenue is project-based and subject to client budget cycles, creating potential volatility.
The company operates in a highly competitive engineering services landscape and may face challenges in scaling its client base and differentiating its methodology.

Competitive Landscape

FPrin competes in the fragmented medical device design and engineering services market, which ranges from large contract development and manufacturing organizations (CDMOs) to small specialist consultancies. Differentiation is based on technical expertise, process, and niche focus areas like drug delivery.